St Vincents Hospital, Darlinghurst, NSW, Australia.
Speech Pathology, Faculty of Health Sciences, The University of Sydney, Sydney, NSW, Australia.
Int J Lang Commun Disord. 2019 Nov;54(6):894-901. doi: 10.1111/1460-6984.12492. Epub 2019 Jul 30.
Oropharyngeal dysphagia and laryngeal dysfunction are two lesser known complications after lung and heart transplantation. The presence of these features places this immunocompromised population at high risk of pulmonary complications and subsequent medical deterioration. Early identification of swallowing and voice dysfunction would be beneficial to optimize management.
To examine the association between patient risk factors and postoperative outcomes with referral to speech pathology (SP) following signs of swallowing and voice dysfunction.
METHODS & PROCEDURES: A retrospective review was conducted on demographic data, patient risk factors and postoperative course in 284 patients following lung and/or heart transplantation between 2010 and 2013. Variables were analysed for any association between pre- and postoperative factors and SP referral.
OUTCOMES & RESULTS: A total of 24% were referred to SP with a mean age of 47 years. Binary logistic regression identified a statistically significant association between the number of intubations (odds ratio (OR) = 2.066, p = 0.028), intubation duration (OR = 1.004, p < 0.01), length of stay in the intensive care unit (ICU) (OR = 1.068, p < 0.01), and number of ICU admissions (OR = 1.384, p = 0.046) and SP referral. Intubation time and the total days in ICU were greater for patients referred to SP. Mortality also increased for these variables and for the numbers of reintubations and readmissions. Analysis of pre-operative risk factors revealed cerebrovascular disease to be a significant predictor of SP referral (OR = 6.747, p = 0.032).
CONCLUSIONS & IMPLICATIONS: This study demonstrates significant clinical indicators for referral to SP for the management of oropharyngeal dysphagia and laryngeal dysfunction in patients after lung or heart transplantation. Further studies are needed to investigate the most efficacious intervention approaches to manage swallowing and voice dysfunction in these patients.
咽和喉功能障碍是肺和心脏移植后两种不太为人知的并发症。这些特征使这些免疫功能低下的人群面临肺部并发症和随后的病情恶化的高风险。早期发现吞咽和声音功能障碍将有利于优化管理。
研究患者的风险因素与术后结果之间的关系,以及在出现吞咽和声音功能障碍后转介给言语病理学家(SP)的情况。
对 2010 年至 2013 年间接受肺和/或心脏移植的 284 名患者的人口统计学数据、患者风险因素和术后过程进行了回顾性分析。分析了术前和术后因素与转介 SP 之间的任何关联。
共有 24%的患者转介给 SP,平均年龄为 47 岁。二项逻辑回归分析确定了插管次数(比值比(OR)=2.066,p=0.028)、插管时间(OR=1.004,p<0.01)、重症监护病房(ICU)住院时间(OR=1.068,p<0.01)和 ICU 入院次数(OR=1.384,p=0.046)与转介 SP 之间存在统计学显著关联。转介给 SP 的患者的插管时间和 ICU 总天数都更长。这些变量的死亡率也更高,还有再插管和再入院的数量。对术前风险因素的分析表明,脑血管疾病是转介 SP 的显著预测因素(OR=6.747,p=0.032)。
本研究表明,对于肺或心脏移植后患者的口咽吞咽和喉功能障碍,存在显著的临床指标需要转介给 SP 进行管理。需要进一步研究以调查最有效的干预方法来管理这些患者的吞咽和声音功能障碍。